As of Feb 12
| +0.56 / +7.71%|
The 2 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a +117.39% increase from the last price of 7.82.
The current consensus among 2 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.